ArticleCancers2021

MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer.

Justyna Magdalena Hermanowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.